These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31039251)

  • 41. Drug resistance profile of human Mycobacterium avium complex strains from India.
    Venugopal D; Kumar S; Isa M; Bose M
    Indian J Med Microbiol; 2007 Apr; 25(2):115-20. PubMed ID: 17582180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Mycobacterium avium-intracellulare complex: a great leap forward.
    Alffenaar JC; van Ingen J
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i1-i2. PubMed ID: 28922812
    [No Abstract]   [Full Text] [Related]  

  • 43. Susceptibility testing of Mycobacterium avium complex isolates.
    Heifets L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1759-67. PubMed ID: 8843278
    [No Abstract]   [Full Text] [Related]  

  • 44. Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics.
    Ruth MM; Raaijmakers J; van den Hombergh E; Aarnoutse R; Svensson EM; Susanto BO; Simonsson USH; Wertheim H; Hoefsloot W; van Ingen J
    Clin Microbiol Infect; 2022 Mar; 28(3):448.e1-448.e7. PubMed ID: 34332109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
    J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.
    Bermudez LE; Kolonoski P; Wu M; Aralar PA; Inderlied CB; Young LS
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1870-4. PubMed ID: 10428905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease.
    Negatu DA; Shin SJ; Kim SY; Jhun BW; Dartois V; Dick T
    J Infect Dis; 2024 Aug; 230(2):e241-e246. PubMed ID: 38150401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
    Kobashi Y; Abe M; Mouri K; Obase Y; Kato S; Oka M
    J Infect Chemother; 2012 Aug; 18(4):436-43. PubMed ID: 22205543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease.
    Hasegawa N; Nishimura T; Watabnabe M; Tasaka S; Nakano Y; Yamazaki K; Hashimoto S; Nishimura M; Ishizaka A
    Pulm Pharmacol Ther; 2009 Jun; 22(3):190-3. PubMed ID: 19061965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice.
    Inderlied CB; Kolonoski PT; Wu M; Young LS
    Antimicrob Agents Chemother; 1989 Feb; 33(2):176-80. PubMed ID: 2719461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.
    Mehta RT
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1893-902. PubMed ID: 8843300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controversies in the management of Mycobacterium avium complex infection in AIDS patients.
    Peloquin CA
    Ann Pharmacother; 1993; 27(7-8):928-37. PubMed ID: 8364280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infection.
    Yajko DM; Nassos PS; Sanders CA; Hadley WK
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1621-5. PubMed ID: 1929335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC) strains isolated in Italy from AIDS-patients.
    Fattorini L; Hu CQ; Jin SH; Santoro C; Tsang AY; Mascellino MT; Mandler F; Orefici G
    Zentralbl Bakteriol; 1992 Apr; 276(4):512-20. PubMed ID: 1611208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of new therapies for infection due to the Mycobacterium avium complex: appropriate use of in vitro and in vivo testing.
    Grosset JH
    Clin Infect Dis; 1994 Apr; 18 Suppl 3():S233-6. PubMed ID: 8204775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex.
    Hosoda K; Koyama N; Kanamoto A; Tomoda H
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30995807
    [No Abstract]   [Full Text] [Related]  

  • 60. Development of an in vivo-mimic silkworm infection model with Mycobacterium avium complex.
    Yagi A; Yamazaki H; Terahara T; Yang T; Hamamoto H; Imada C; Tomoda H; Uchida R
    Drug Discov Ther; 2021 Jan; 14(6):287-295. PubMed ID: 33250497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.